Compugen to Present at Single Cell Genomics 2023 Meeting
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...
Source: prnewswire.com
Page 11 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Compugen Today - Breaking & Trending Today
Compugen Gets Patent In Japan For Combination Of Anti-PVRIG, TIGIT, PD-1 Antibody To Treat Cancer
(RTTNews) - Compugen Ltd. (CGEN) announced the Japanese Patent Office has granted Compugen a patent for treating cancer with a triple combination ...
Source: businessinsider.com
Compugen Expands Intellectual Property with New Japanese Patent for the Triple Combination of any Anti-PVRIG, TIGIT and PD-1 Antibody for the Treatment of Cancer
HOLON, Israel, Oct. 2, 2023 /PRNewswire/ -- Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Japanese...
Source: marketscreener.com
Compugen Ltd. (NASDAQ:CGEN) Short Interest Up 12.2% in August
Compugen Ltd. (NASDAQ:CGEN – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 1,750,000 shares, a growth of 12.2% from the August 15th total of 1,560,000 shares. Based on an average trading volume of 377,800 shares, the […]
Source: dailypolitical.com
Compugen (NASDAQ:CGEN) Share Price Passes Above 200 Day Moving Average of $0.95
Compugen Ltd. (NASDAQ:CGEN – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.95 and traded as high as $1.07. Compugen shares last traded at $1.07, with a volume of 59,977 shares changing hands. Wall Street Analyst Weigh In CGEN has been […]
Source: modernreaders.com